- Home
- ONCY vs CNTB Comparison
ONCY vs CNTB Comparison
Compare ONCY & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONCY
- CNTB
- Stock Information
- Founded
- ONCY 1998
- CNTB 2012
- Country
- ONCY Canada
- CNTB United States
- Employees
- ONCY N/A
- CNTB N/A
- Industry
- ONCY Pharmaceuticals and Biotechnology
- CNTB Biotechnology: Pharmaceutical Preparations
- Sector
- ONCY Health Care
- CNTB Health Care
- Exchange
- ONCY Nasdaq
- CNTB Nasdaq
- Market Cap
- ONCY 53.6M
- CNTB 55.2M
- IPO Year
- ONCY 1999
- CNTB 2021
- Fundamental
- Price
- ONCY $0.56
- CNTB $0.69
- Analyst Decision
- ONCY Strong Buy
- CNTB Strong Buy
- Analyst Count
- ONCY 4
- CNTB 1
- Target Price
- ONCY $4.00
- CNTB $8.00
- AVG Volume (30 Days)
- ONCY 224.8K
- CNTB 17.3K
- Earning Date
- ONCY 03-07-2025
- CNTB 03-31-2025
- Dividend Yield
- ONCY N/A
- CNTB N/A
- EPS Growth
- ONCY N/A
- CNTB N/A
- EPS
- ONCY N/A
- CNTB N/A
- Revenue
- ONCY N/A
- CNTB $26,033,000.00
- Revenue This Year
- ONCY N/A
- CNTB $997.61
- Revenue Next Year
- ONCY N/A
- CNTB N/A
- P/E Ratio
- ONCY N/A
- CNTB N/A
- Revenue Growth
- ONCY N/A
- CNTB N/A
- 52 Week Low
- ONCY $0.55
- CNTB $0.55
- 52 Week High
- ONCY $1.53
- CNTB $2.66
- Technical
- Relative Strength Index (RSI)
- ONCY 27.91
- CNTB 29.72
- Support Level
- ONCY $0.58
- CNTB $0.80
- Resistance Level
- ONCY $0.65
- CNTB $0.84
- Average True Range (ATR)
- ONCY 0.03
- CNTB 0.06
- MACD
- ONCY -0.00
- CNTB -0.01
- Stochastic Oscillator
- ONCY 1.34
- CNTB 0.30
About ONCY Oncolytics Biotech Inc.
Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer among others.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.